JACC: Basic to Translational Science (Aug 2017)

Lipoprotein(a) Induces Human Aortic Valve Interstitial Cell Calcification

  • Bin Yu, PhD,
  • Anouar Hafiane, PhD,
  • George Thanassoulis, MD,
  • Leah Ott, BS,
  • Nial Filwood, MD,
  • Marta Cerruti, PhD,
  • Ophélie Gourgas, MS,
  • Dominique Shum-Tim, MD,
  • Hamood Al Kindi, MD,
  • Benoit de Varennes, MD,
  • Alawi Alsheikh-Ali, MD, PhD,
  • Jacques Genest, MD,
  • Adel Schwertani, DM, PhD

DOI
https://doi.org/10.1016/j.jacbts.2017.03.015
Journal volume & issue
Vol. 2, no. 4
pp. 358 – 371

Abstract

Read online

Lipoprotein(a), or Lp(a), significantly increased alkaline phosphatase activity, release of phosphate, calcium deposition, hydroxyapatite, cell apoptosis, matrix vesicle formation, and phosphorylation of signal transduction proteins; increased expression of chondro-osteogenic mediators; and decreased SOX9 and matrix Gla protein (p < 0.001). Inhibition of MAPK38 and GSK3β significantly reduced Lp(a)-induced calcification of human aortic valve interstitial cells (p < 0.001). There was abundant presence of Lp(a) and E06 immunoreactivity in diseased human aortic valves. The present study demonstrates a causal effect for Lp(a) in aortic valve calcification and suggests that interfering with the Lp(a)pathway could provide a novel therapeutic approach in the management of this debilitating disease.

Keywords